The New York University Medical Center (NYUMC) has established a multicategorical GCRC at Bellevue Hospital Center, providing inpatient facilities for 12 beds (mixed pediatrics (4) and adults (8)) and 6 outpatient examination rooms. In addition, reconstruction is now being completed on a GCRC satellite outpatient unit which will contain 6 additional examination rooms. This proposal requests approval for years 34-38 of operation. The PI. of the NYUMC GCRC appointed William N. Rom, MD, MPH, Program Director (effective 7/1/1991) who has established a new clinical research theme emphasizing molecular biology and the diseases incompassing HIV infection and cancer. The NYU effort is multidisciplinary, with extensive collaboration among departments and between basic and clinical scientists. The GCRC has undergone extensive renovation to accommodate these new directions. New projects emphasize maternal-fetal HIV transmission, new approaches to therapies in HIV infection, use of cytokine approaches in the new epidemic of tuberculosis, novel molecular therapies in cancer, molecular endocrinology, modulating inflammation and fibrotic processes by altering adhesion molecules, growth factors or signal transduction, and evaluating the brain with exciting new technologies including PET and MRI. The GCRC is utilized by practically all of the clinical departments, and the program director is a member of the executive committee of the Skirball Institute for Biomolecular Medicine which is comprised of NYU'S leading basic science researchers. A newly constituted executive advisory committee reviews all protocols for approval and prioritization. The GCRC core laboratory has been redesigned to address the future in molecular and cell biology. New equipment has been purchased, including a DNA synthesizer, thermal cycler, gel electrophoresis apparatus, tissue culture hoods and incubators for performing routine molecular biology functions on GCRC protocols. More importantly, the core laboratory will provide an educational function by teaching clinical investigators research skills in molecular biology to compete for funding to develop new therapies for clinical studies using approaches to evaluate cytokines, growth factors, and gene therapy. A CDMAS has been established to provide NYU GCRC investigators with the most advanced computer and biostatistical consultation available. Located within Bellevue Hospital Center, the GCRC has access to large populations for study, including many HIV-infected individuals and minorities. NYU and Bellevue work closely together to assure the highest quality care and research investigations.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
General Clinical Research Centers Program (M01)
Project #
Application #
Study Section
General Clinical Research Centers Committee (CLR)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York University
Internal Medicine/Medicine
Schools of Medicine
New York
United States
Zip Code
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Ebbert, Mark T W; Boehme, Kevin L; Wadsworth, Mark E et al. (2016) Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement 12:121-129
Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43
Homann, O R; Misura, K; Lamas, E et al. (2016) Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness. Mol Psychiatry 21:1690-1695
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Li, Yi; Tsui, Wai; Rusinek, Henry et al. (2015) Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease. J Nucl Med 56:270-3
Ghani, Mahdi; Reitz, Christiane; Cheng, Rong et al. (2015) Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. JAMA Neurol 72:1313-23
Beecham, Gary W; Dickson, Dennis W; Scott, William K et al. (2015) PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology 84:972-80

Showing the most recent 10 out of 470 publications